Breakthrough ovarian cancer drug offers patients more time and better quality of life

A breakthrough drug for ovarian cancer that is kinder on the body and extends lives is now available on the NHS.

The drug, called mirvetuximab soravtansine, is a known as a “biological missile” as it delivers chemotherapy drugs direct to the cancerous tissue rather than to the whole body – reducing debilitating side-effects.

Up to 400 patients a year in England could benefit from the new treatment – the first for hard-to-treat ovarian cancer in 20 years.
There are nearly 7,750 cases of ovarian cancer in the UK each year.

Subscribe to our channel here: https://bbc.in/bbcnews

For the latest news download the BBC News app or visit BBC.com/news

#BBCNews #OvarianCancer #NHS